| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4126654 | Otolaryngology - Head and Neck Surgery | 2007 | 7 Pages |
Abstract
Epigenetic-modifying agents show potential for treatment of radioablation-resistant thyroid cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Matthew J. MD, Matthew P. BS, Kimberly BS, Frederick E. PhD,